作者:Gabriella Gentile、Giovanni Bernasconi、Alfonso Pozzan、Giancarlo Merlo、Paola Marzorati、Paul Bamborough、Benjamin Bax、Angela Bridges、Caroline Brough、Paul Carter、Geoffrey Cutler、Margarete Neu、Mia Takada
DOI:10.1016/j.bmcl.2011.06.050
日期:2011.8
The discovery of a novel series of 2-(4-pyridyl)thienopyridinone GSK-3 beta inhibitors is reported. X-ray crystallography reveals its binding mode and enables rationalization of the SAR. The initial optimization of the template for improved cellular activity and predicted CNS penetration is also presented. (C) 2011 Elsevier Ltd. All rights reserved.